b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30924084</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>05</Month>\n            <Day>26</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>05</Month>\n            <Day>26</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1559-0100</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>65</Volume>\n                    <Issue>2</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>08</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Endocrine</Title>\n                <ISOAbbreviation>Endocrine</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Association between vitamin D receptor gene polymorphisms and Graves\' disease: a systematic review and meta-analysis.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>244-251</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s12020-019-01902-3</ELocationID>\n            <Abstract>\n                <AbstractText Label="PURPOSE">The pathogenesis of Graves\' disease (GD) and orbitopathy (GO) is not completely elucidated. On the other hand, vitamin D receptor (VDR) gene polymorphisms have been associated with vulnerability to a plethora of chronic autoimmune diseases. The primary aim of this study was to synthesize evidence on the association between VDR gene polymorphisms and GD. Secondary aim was to investigate their association with GO.</AbstractText>\n                <AbstractText Label="METHODS">A comprehensive search was conducted in PubMed, CENTRAL and Scopus, up to December 8, 2018. Data were expressed as odds ratio (OR) with 95% confidence intervals (CI). Heterogeneity was quantified with I<sup>2</sup> index.</AbstractText>\n                <AbstractText Label="RESULTS">Ten studies were included in the qualitative and quantitative analysis. TT subtype of TaqI polymorphism was associated with an increased risk of GD compared with Tt and tt polymorphisms (OR: 1.42; 95% CI, 1.05-1.94, p\xe2\x80\x89=\xe2\x80\x890.025), whereas tt was associated with a lower risk of GD, compared with TT and Tt polymorphisms (OR: 0.79; 95% CI, 0.62-0.99, p\xe2\x80\x89=\xe2\x80\x890.043). No association was found for ApaI, BsmI, and FokI polymorphisms. The bb subtype of BsmI polymorphism was associated with a lower risk in Asian, but with a higher GD risk in Caucasian populations, compared with BB/Bb subtypes. No eligible study was found regarding the association between VDR gene polymorphisms and the risk of GO.</AbstractText>\n                <AbstractText Label="CONCLUSIONS">The TT subtype of the TaqI polymorphism was associated with a higher susceptibility for GD compared with Tt and tt. Regarding BsmI, the bb subtype was associated with increased GD risk in Caucasians, whereas it is protective in Asians.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Veneti</LastName>\n                    <ForeName>Stavroula</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Endocrinology and Diabetes, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Anagnostis</LastName>\n                    <ForeName>Panagiotis</ForeName>\n                    <Initials>P</Initials>\n                    <Identifier Source="ORCID">0000-0002-8949-4312</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Endocrinology and Diabetes, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece. anagnwstis.pan@yahoo.gr.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Adamidou</LastName>\n                    <ForeName>Fotini</ForeName>\n                    <Initials>F</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Endocrinology and Diabetes, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Artzouchaltzi</LastName>\n                    <ForeName>Aikaterini-Maria</ForeName>\n                    <Initials>AM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>1st University Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Boboridis</LastName>\n                    <ForeName>Kostas</ForeName>\n                    <Initials>K</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>1st University Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Kita</LastName>\n                    <ForeName>Marina</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Endocrinology and Diabetes, Hippokration General Hospital of Thessaloniki, Thessaloniki, Greece.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D017418">Meta-Analysis</PublicationType>\n                <PublicationType UI="D000078182">Systematic Review</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>03</Month>\n                <Day>28</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Endocrine</MedlineTA>\n            <NlmUniqueID>9434444</NlmUniqueID>\n            <ISSNLinking>1355-008X</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D018167">Receptors, Calcitriol</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006111" MajorTopicYN="N">Graves Disease</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012150" MajorTopicYN="N">Polymorphism, Restriction Fragment Length</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018167" MajorTopicYN="N">Receptors, Calcitriol</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Gene</Keyword>\n            <Keyword MajorTopicYN="Y">Graves\xe2\x80\x99 disease</Keyword>\n            <Keyword MajorTopicYN="Y">Polymorphisms</Keyword>\n            <Keyword MajorTopicYN="Y">VDR</Keyword>\n            <Keyword MajorTopicYN="Y">Vitamin D receptor</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>01</Month>\n                <Day>21</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>03</Month>\n                <Day>12</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>30</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>5</Month>\n                <Day>27</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>30</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30924084</ArticleId>\n            <ArticleId IdType="doi">10.1007/s12020-019-01902-3</ArticleId>\n            <ArticleId IdType="pii">10.1007/s12020-019-01902-3</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>J Clin Endocrinol Metab. 2002 Jun;87(6):2564-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12050214</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Front Endocrinol (Lausanne). 2016 Mar 08;7:21</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27014188</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Epidemiol. 2010 Sep;25(9):603-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20652370</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Immunol. 2008 Jan;28(1):21-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17943423</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Acta Biochim Pol. 2008;55(2):371-80</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18506225</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Endocrine. 2013 Apr;43(2):318-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23065592</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>JAMA. 2000 Apr 19;283(15):2008-12</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10789670</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Mol Sci. 2018 May 30;19(6):</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29849001</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Croat Med J. 2005 Aug;46(4):639-46</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16100768</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Opin Pharmacol. 2010 Aug;10(4):482-96</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20427238</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Thyroid. 2000 May;10(5):375-80</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10884183</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nutrients. 2015 May 21;7(5):3813-27</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26007334</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Rev Endocr Metab Disord. 2012 Mar;13(1):21-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21845364</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Endocrine. 2013 Oct;44(2):448-53</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23397523</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Endocrinol. 2018 Mar 22;2018:2846943</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">29765404</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Endocrinol (Oxf). 2009 Jun;70(6):938-45</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18782354</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Front Immunol. 2017 Jan 20;7:697</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28163705</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Immunol. 2007 Aug 1;179(3):1634-47</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">17641030</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Endocr Pract. 2012 Mar-Apr;18(2):132-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21803714</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Thyroid. 2005 Oct;15(10):1125-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16279845</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Science. 1983 Sep 16;221(4616):1181-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">6310748</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Exp Immunol. 2014 Nov;178(2):262-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25046415</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Cell Mol Immunol. 2011 May;8(3):243-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21278761</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Clin Endocrinol (Oxf). 2004 May;60(5):618-24</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15104566</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Endocrinol Invest. 2017 Mar;40(3):257-261</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27664101</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'